Form 4: Pfizer SVP & Controller Jennifer B. Damico Reports Stock Sale
SEC Form 4 Filing
Jennifer B. Damico, SVP & Controller of Pfizer Inc., reported the sale of 5,154 shares of common stock at a price of $28.66 on August 13, 2024.
Summary
- On August 13, 2024, Jennifer B. Damico, the SVP & Controller of Pfizer Inc., sold 5,154 shares of Pfizer's common stock.
- The sale price was $28.66 per share.
- Following the transaction, Damico directly owns 8,582 shares of Pfizer common stock.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of a stock sale by a company insider. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This is a routine disclosure of insider trading activity. It is common for company executives to buy and sell shares of their company's stock. The disclosure is required by the SEC to ensure transparency and prevent insider trading.
Stakeholder Impact
- The stock sale may have a minor impact on shareholders, depending on the size of the transaction and the market's perception of the insider's motives.
Key Dates
| Date | Description |
|---|---|
| 08/13/2024 | Date of stock sale transaction |
| 08/14/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.